SOLV — Solventum Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $90.38
- YTD price return
- +14.06%
- YTD total return
- +14.06%
- Market cap
- 15.3B
- Enterprise value
- 20.4B
- Shares outstanding
- 169.7M
- 52W low
- $62.38
- 52W high
- $94.16
- From 52W high
- -4.01%
- From 52W low
- +44.89%
- 52W range
- 88%$62.38–$94.16
Volume
- Rel volume
- 2.69×
- 30D volume
- 1.2M
- 30D $ vol
- 101.8M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- +$100K
Form 4 transactions by trade date, as filed; latest on file 2026-03-10.
Fundamentals
- Sales (ttm)
- 8.2B
- Sales/share
- $48.09
- EPS (ttm)
- $0.90
- FCF (ttm)
- 0
- FCF/share
- $0.00
- Book value/share
- $28.31
- Net margin
- 1.91%
- ROE
- 3.25%
- ROA
- 1.10%
- Debt / equity
- 0.95×
- Current ratio
- 1.03
Growth (CAGR, ttm) · 10Y
- Sales
- -2.85%-0.15%n/an/a
- Net income
- -89.78%-54.34%n/an/a
- Shares
- -2.14%-0.57%n/an/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -89.71%-54.45%n/an/a
- Sales/share
- -0.72%+0.48%n/an/a
- Book value/share
- -1.53%-24.98%n/an/a
- Price
- +36.39%+4.78%n/an/a
- Total return
- +36.39%+4.78%n/an/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 100.7×
- Fwd P/E
- 12.4×
- P/S (ttm)
- 1.9×
- P/B (mrq)
- 3.2×
- EV/EBITDA (fy)
- 20.9×
- EV/Sales (ttm)
- 2.5×
- FCF yield (ttm)
- 0.00%
- Buyback yield (realized, 1y)
- 2.14%
- Shareholder yield (realized, 1y)
- 2.14%
- Buyback yield (cash, ttm)
- 2.63%
- Shareholder yield (cash, ttm)
- 2.63%
Performance · price returntotal return · as of 2026-11-06#
Data provided bySource: Twelve DataFundamentals#
Operating income
YoY −96.0%EPS (diluted)
YoY n/mFree cash flow
YoY n/mTTM: operating cash flow $310M, capex −$310M
Q3 2026: operating cash flow $177M, capex −$80M
Shares (diluted)
YoY −2.6%Net income
YoY n/mAbout Solventum#
Data provided bySource: Twelve DataSolventum Corporation is a healthcare company that develops and commercializes a broad portfolio of products and software designed to address clinical and operational needs across care settings. Its Medsurg business provides wound care, skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, and medical electrodes. The Dental Solutions segment offers products used in restorative and orthodontic workflows, including brackets, aligners, cements, and bonding agents. Through Health Information Systems, Solventum supplies software and services that support physician documentation, coding automation, speech recognition, and data visualization for healthcare organizations. The company serves customers in the United States and internationally through direct sales, distribution, key account management, inside sales, and e-commerce. Headquartered in Eagan, Minnesota, Solventum focuses on technologies that support safer, more efficient healthcare delivery.
Eagan, MN·20,584 employees·Medical Instruments & Supplies·solventum.com·As of Oct 28, 2026
Recent filings#
- Nov 5Earnings · Earnings release — EPS $1.45 vs $1.35 est. (+7.4%); revenue $1.95B (−7% y/y) 3.7%
- Aug 5Earnings · Earnings release — EPS $2.55 vs $1.91 est. (+33.5%); revenue $2.21B (+2% y/y) 5.2%
- Aug 58-K · Solventum Announces Intent to Separate its Health Information Systems Business
ETFs holding SOLV#
27 of the 193 ETFs ChartRow carries live hold SOLV. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| VBR | Vanguard Small-Cap Value ETF | 0.2% |
| RSP | Invesco S&P 500 Equal Weight ETF | 0.2% |
| XLV | Health Care Select Sector SPDR Fund | 0.2% |
| VHT | Vanguard Health Care ETF | 0.2% |
| VB | Vanguard Small-Cap ETF | 0.1% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.1% |
| IWR | iShares Russell Midcap ETF | 0.1% |
| SPYV | SPDR Portfolio S&P 500 Value ETF | 0.0% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +16.98% | -0.79% |
| JNJ | Johnson & Johnson | +8.42% | +1.43% |
| ABBV | AbbVie Inc. | +9.23% | +1.07% |
| MRK | Merck & Co. Inc. | +3.37% | -0.14% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +4.74% | -0.40% |
| NVS | Novartis AG | +15.46% | +0.38% |
| TMO | Thermo Fisher Scientific Inc. | +5.81% | +2.63% |
| AMGN | Amgen Inc. | +14.36% | +0.03% |
